Menu
Back to Journals » OncoTargets and Therapy » Volume 4
Review
Rationale for targeting VEGF, FGF, and PDGF for the treatment of NSCLC
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 14,792 | Dovepress* | 10,891+ | 3,311 | 14,202 | |
| PubMed Central* | 3,901 | 2,800 | 6,701 | ||
| Totals | 14,792 | 6,111 | 20,903 | ||
|
*Since 30 May 2011 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 2 |
View citations on PubMed Central and Google Scholar